Abbott (ABT), Reckitt Unit Defeat Infant-formula Sickness Claims - Bloomberg
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Abbott Laboratories (NYSE: ABT) | Delayed: 102.27 +1.76 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $100.51 | 52 Week High | $46.38 | |||
| Open | $101.50 | 52 Week Low | $36.00 | |||
| Day High | $102.69 | P/E | 68.18 | |||
| Day Low | $99.91 | EPS | $1.50 | |||
| Volume | 4,686,368 | |||||
